“We will continue to pursue legal action against those who provide potentially unsafe and ineffective compounded ‘semaglutide’ products and knowingly deceive patients who are seeking treatment, thereby eroding public trust in the safety of FDA-approved medicines,” said Doug Langa, executive vice president, North America operations and president of Novo Nordisk.
‘Larger Evidentiary Mosaic:’ 7th Circ. Revives Smoothie Slip-And-Fall Suit Against Costco
“Here, Cruz’s statements do not even stand alone. They are
